Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey R Bishop

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Clinical and Translational Science|May 31, 2021
Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosingJeffrey R Bishop
Handbook of Clinical Neurology|January 13, 2018
PharmacogeneticsJeffrey R Bishop
Pharmacogenomics|August 29, 2015
Atomoxetine pharmacogenetics: associations with pharmacokinetics, treatment response and tolerabilityJacob T Brown, Jeffrey R Bishop
The Annals of Pharmacotherapy|July 1, 2010
Anticholinergic use in children and adolescents after initiation of antipsychotic therapyIrene Seunghyun Hong, Jeffrey R Bishop
Pharmacogenomics|June 24, 2004
Neuropsychiatric pharmacogenetics: moving toward a comprehensive understanding of predicting risks and responseJeffrey R Bishop, Vicki L Ellingrod
Pharmacogenomics|July 27, 2011
Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complicationsAmy K Lee, Jeffrey R Bishop
Pharmacogenomics|March 19, 2019
A systematic review of genome-wide association studies of antipsychotic responseJosiah D Allen, Jeffrey R Bishop
Neuropsychiatric Disease and Treatment|August 30, 2008
Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophreniaJeffrey R Bishop, Mani N Pavuluri
Pharmacogenomics|December 11, 2014
Genetic determinants of selective serotonin reuptake inhibitor related sexual dysfunctionJames M Stevenson, Jeffrey R Bishop
Pharmacotherapy|August 25, 2017
Precision Pharmacotherapy Enables Precision MedicineJeffrey R Bishop, Vicki L Ellingrod
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Clinical and Translational Science|May 31, 2021
Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosingJeffrey R Bishop
Handbook of Clinical Neurology|January 13, 2018
PharmacogeneticsJeffrey R Bishop
Pharmacogenomics|August 29, 2015
Atomoxetine pharmacogenetics: associations with pharmacokinetics, treatment response and tolerabilityJacob T Brown, Jeffrey R Bishop
The Annals of Pharmacotherapy|July 1, 2010
Anticholinergic use in children and adolescents after initiation of antipsychotic therapyIrene Seunghyun Hong, Jeffrey R Bishop
Pharmacogenomics|June 24, 2004
Neuropsychiatric pharmacogenetics: moving toward a comprehensive understanding of predicting risks and responseJeffrey R Bishop, Vicki L Ellingrod
Pharmacogenomics|July 27, 2011
Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complicationsAmy K Lee, Jeffrey R Bishop
Pharmacogenomics|March 19, 2019
A systematic review of genome-wide association studies of antipsychotic responseJosiah D Allen, Jeffrey R Bishop
Neuropsychiatric Disease and Treatment|August 30, 2008
Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophreniaJeffrey R Bishop, Mani N Pavuluri
Pharmacogenomics|December 11, 2014
Genetic determinants of selective serotonin reuptake inhibitor related sexual dysfunctionJames M Stevenson, Jeffrey R Bishop
Pharmacotherapy|August 25, 2017
Precision Pharmacotherapy Enables Precision MedicineJeffrey R Bishop, Vicki L Ellingrod
Pageof 16